Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DEANA MIKHALKOVA

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1891016515
CMS profile
1214243
Location
ST LOUIS, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$1,660.51

13 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $930.00 1
Food and Beverage $717.46 11
Education $13.05 1

By paying entity

PY2021 · entire year · sorted by reported total

Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DEANA MIKHALKOVA

NPI 1891016515 · CMS profile ID 1214243

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

ST LOUIS, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1891016515?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DEANA MIKHALKOVA, NPI 1891016515, CMS profile ID 1214243. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1891016515?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). DEANA MIKHALKOVA, NPI 1891016515, CMS profile ID 1214243. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1891016515?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
DEANA MIKHALKOVA, NPI 1891016515, CMS profile ID 1214243, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1891016515?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

13 matching records · $1,660.51 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 13 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–13 of 13.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $20.6711/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830024605 CMS
Abbott Laboratories $110.1410/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815785415 CMS
CVRx, Inc. $149.7610/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851081281 CMS
Abbott Laboratories $7.6610/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815716099 CMS
Abbott Laboratories $2.7910/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815716103 CMS
E.R. Squibb & Sons, L.L.C. $72.2609/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783461695 CMS
Novartis Pharmaceuticals Corporation $13.4306/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813081811 CMS
Lantheus Medical Imaging, Inc. $22.2905/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 854126827 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $125.0004/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763365476 CMS
AstraZeneca Pharmaceuticals LP $930.0004/15/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829540727 CMS
Abbott Laboratories $13.0502/17/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818418513 CMS
Abbott Laboratories $9.0301/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818391569 CMS
Abbott Laboratories $184.4301/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818391571 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $40.14 2
PY2020 $13.52 1
PY2021 $1,660.51 13
PY2022 $385.60 10
PY2023 $806.03 28
PY2024 $639.09 23
PY2025 $2,419.00 29

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $5,136.67 1
PY2022 Principal investigator $27,450.14 3
PY2021 Principal investigator $29,183.21 24
PY2020 Principal investigator $118,440.09 110
PY2019 Principal investigator $154,892.71 184

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

184 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boehringer Ingelheim International GmbH $1,831.00 12/13/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927141
Principal investigator 1 Boehringer Ingelheim International GmbH $1,603.00 12/13/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927143
Principal investigator 1 Boehringer Ingelheim International GmbH $1,264.00 12/03/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703927513
Principal investigator 1 Boehringer Ingelheim International GmbH $212.00 12/03/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703927515
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 12/03/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703927517
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 12/03/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703927519
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 12/03/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703927521
Principal investigator 1 Boehringer Ingelheim International GmbH $400.00 12/03/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703927905
Principal investigator 1 Boehringer Ingelheim International GmbH $20.43 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703924779
Principal investigator 1 Boehringer Ingelheim International GmbH $20.43 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703924781
Principal investigator 1 Boehringer Ingelheim International GmbH $10.21 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703924783
Principal investigator 1 Boehringer Ingelheim International GmbH $30.64 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703924787
Principal investigator 1 Boehringer Ingelheim International GmbH $20.43 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703924789
Principal investigator 1 Boehringer Ingelheim International GmbH $40.86 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703924793
Principal investigator 1 Boehringer Ingelheim International GmbH $20.43 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703924839
Principal investigator 1 Boehringer Ingelheim International GmbH $29.75 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703924841
Principal investigator 1 Boehringer Ingelheim International GmbH $38.54 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925263
Principal investigator 1 Boehringer Ingelheim International GmbH $10.21 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925275
Principal investigator 1 Boehringer Ingelheim International GmbH $40.86 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925283
Principal investigator 1 Boehringer Ingelheim International GmbH $30.64 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925313
Principal investigator 1 Boehringer Ingelheim International GmbH $30.64 12/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703926775
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $2,033.16 11/30/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704735701
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,558.02 11/30/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704735703
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $4,574.60 11/30/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704735705
Principal investigator 1 Boehringer Ingelheim International GmbH $754.00 11/22/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703924137
Principal investigator 1 Boehringer Ingelheim International GmbH $1,157.00 11/22/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703924225
Principal investigator 1 Boehringer Ingelheim International GmbH $1,224.00 11/22/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703924227
Principal investigator 1 Boehringer Ingelheim International GmbH $1,264.00 11/22/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703924503
Principal investigator 1 Novartis Pharmaceuticals Corporation $14,400.00 11/20/2019 Non-covered Recipient Entity
SAINT LOUIS UNIVERSITY SOLUTIONS
PROSPECTIVE COMPARISON OF ARNI WITH ARB GIVEN FOLLOWING STABILIZATION IN DECOMPENSATED HFPEF (PARAGLIDE-HFPEF) No dispute reported 06/30/2026 640725775
Principal investigator 1 Boehringer Ingelheim International GmbH $360.00 11/18/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923127
Principal investigator 1 Boehringer Ingelheim International GmbH $600.00 11/18/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923841
Principal investigator 1 Boehringer Ingelheim International GmbH $41.41 11/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925095
Principal investigator 1 Boehringer Ingelheim International GmbH $41.41 11/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925097
Principal investigator 1 Boehringer Ingelheim International GmbH $31.06 11/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925099
Principal investigator 1 Boehringer Ingelheim International GmbH $41.41 11/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925105
Principal investigator 1 Boehringer Ingelheim International GmbH $31.06 11/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925107
Principal investigator 1 Boehringer Ingelheim International GmbH $31.06 11/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925109
Principal investigator 1 Boehringer Ingelheim International GmbH $60.30 11/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703925111
Principal investigator 1 Boehringer Ingelheim International GmbH $31.06 11/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703927683
Principal investigator 1 Boehringer Ingelheim International GmbH $31.06 11/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703927685
Principal investigator 1 Boehringer Ingelheim International GmbH $31.06 11/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703927687
Principal investigator 1 Boehringer Ingelheim International GmbH $31.06 11/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703927689
Principal investigator 1 Boehringer Ingelheim International GmbH $62.11 11/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703928737
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 11/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703924291
Principal investigator 1 Boehringer Ingelheim International GmbH $1,264.00 11/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703924573
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $2,541.44 10/31/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704735697
Principal investigator 1 Boehringer Ingelheim International GmbH $600.00 10/08/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923073
Principal investigator 1 Boehringer Ingelheim International GmbH $1,470.00 10/08/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923075
Principal investigator 1 Boehringer Ingelheim International GmbH $75.00 10/08/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703923077
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,049.73 09/30/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704735695
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $2,033.16 09/30/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 704735699
Principal investigator 1 Boehringer Ingelheim International GmbH $8,800.00 09/11/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703922065
Principal investigator 1 Boehringer Ingelheim International GmbH $2,800.00 09/11/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703926531
Principal investigator 1 Boehringer Ingelheim International GmbH $1,264.00 09/10/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703918309
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 09/10/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703918311
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 09/10/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703918363
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 09/10/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703918365
Principal investigator 1 Boehringer Ingelheim International GmbH $1,831.00 09/06/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703918273
Principal investigator 1 Boehringer Ingelheim International GmbH $1,652.00 09/06/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703918275
Principal investigator 1 Boehringer Ingelheim International GmbH $1,603.00 09/06/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703918277
Principal investigator 1 Boehringer Ingelheim International GmbH $1,264.00 08/06/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703916519
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 08/06/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703917081
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 08/06/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703917083
Principal investigator 1 Boehringer Ingelheim International GmbH $1,330.00 08/06/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703917441
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 08/05/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703917419
Principal investigator 1 Boehringer Ingelheim International GmbH $41.08 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703919895
Principal investigator 1 Boehringer Ingelheim International GmbH $25.84 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703919897
Principal investigator 1 Boehringer Ingelheim International GmbH $30.81 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703919899
Principal investigator 1 Boehringer Ingelheim International GmbH $30.81 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703919901
Principal investigator 1 Boehringer Ingelheim International GmbH $20.54 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703919903
Principal investigator 1 Boehringer Ingelheim International GmbH $30.81 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703919905
Principal investigator 1 Boehringer Ingelheim International GmbH $47.02 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703919907
Principal investigator 1 Boehringer Ingelheim International GmbH $20.54 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703919909
Principal investigator 1 Boehringer Ingelheim International GmbH $20.54 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703919995
Principal investigator 1 Boehringer Ingelheim International GmbH $30.81 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703919999
Principal investigator 1 Boehringer Ingelheim International GmbH $20.54 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703920007
Principal investigator 1 Boehringer Ingelheim International GmbH $20.54 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703920011
Principal investigator 1 Boehringer Ingelheim International GmbH $25.84 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703920087
Principal investigator 1 Boehringer Ingelheim International GmbH $20.54 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703920095
Principal investigator 1 Boehringer Ingelheim International GmbH $41.08 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920107
Principal investigator 1 Boehringer Ingelheim International GmbH $30.81 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920183
Principal investigator 1 Boehringer Ingelheim International GmbH $41.08 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920185
Principal investigator 1 Boehringer Ingelheim International GmbH $30.81 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920187
Principal investigator 1 Boehringer Ingelheim International GmbH $30.81 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920195
Principal investigator 1 Boehringer Ingelheim International GmbH $30.81 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920279
Principal investigator 1 Boehringer Ingelheim International GmbH $20.54 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920283
Principal investigator 1 Boehringer Ingelheim International GmbH $39.52 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920285
Principal investigator 1 Boehringer Ingelheim International GmbH $29.91 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703920289
Principal investigator 1 Boehringer Ingelheim International GmbH $52.76 08/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703925887
Principal investigator 1 Boehringer Ingelheim International GmbH $1,330.00 07/08/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915929
Principal investigator 1 Boehringer Ingelheim International GmbH $754.00 07/08/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915931
Principal investigator 1 Boehringer Ingelheim International GmbH $754.00 07/08/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915933
Principal investigator 1 Boehringer Ingelheim International GmbH $754.00 07/08/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915935
Principal investigator 1 Boehringer Ingelheim International GmbH $754.00 07/08/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703916011
Principal investigator 1 Boehringer Ingelheim International GmbH $20.93 07/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703918643
Principal investigator 1 Boehringer Ingelheim International GmbH $10.46 07/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703918651
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $508.29 06/30/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704735691
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $5,082.89 06/30/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704735693
Principal investigator 1 Boehringer Ingelheim International GmbH $1,330.00 06/12/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912541
Principal investigator 1 Boehringer Ingelheim International GmbH $1,330.00 06/12/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912543
Principal investigator 1 Boehringer Ingelheim International GmbH $1,330.00 06/12/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912545
Principal investigator 1 Boehringer Ingelheim International GmbH $1,264.00 06/12/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912547
Principal investigator 1 Boehringer Ingelheim International GmbH $212.00 06/12/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912549
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 06/12/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912551
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 06/12/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912553
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 06/12/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912555
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 06/12/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912557
Principal investigator 1 Boehringer Ingelheim International GmbH $24.66 06/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915497
Principal investigator 1 Boehringer Ingelheim International GmbH $49.53 06/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915499
Principal investigator 1 Boehringer Ingelheim International GmbH $10.23 06/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915597
Principal investigator 1 Boehringer Ingelheim International GmbH $24.66 06/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915601
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,049.73 05/31/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704735689
Principal investigator 1 Boehringer Ingelheim International GmbH $1,330.00 05/17/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703912223
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 05/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703912049
Principal investigator 1 Boehringer Ingelheim International GmbH $31.19 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703915105
Principal investigator 1 Boehringer Ingelheim International GmbH $31.19 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703915111
Principal investigator 1 Boehringer Ingelheim International GmbH $31.19 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703915113
Principal investigator 1 Boehringer Ingelheim International GmbH $31.19 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703915209
Principal investigator 1 Boehringer Ingelheim International GmbH $31.19 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703915215
Principal investigator 1 Boehringer Ingelheim International GmbH $31.19 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703915219
Principal investigator 1 Boehringer Ingelheim International GmbH $31.19 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703915275
Principal investigator 1 Boehringer Ingelheim International GmbH $26.15 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915283
Principal investigator 1 Boehringer Ingelheim International GmbH $41.59 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915285
Principal investigator 1 Boehringer Ingelheim International GmbH $62.38 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915287
Principal investigator 1 Boehringer Ingelheim International GmbH $62.38 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915289
Principal investigator 1 Boehringer Ingelheim International GmbH $62.38 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915291
Principal investigator 1 Boehringer Ingelheim International GmbH $51.98 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915293
Principal investigator 1 Boehringer Ingelheim International GmbH $41.59 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915295
Principal investigator 1 Boehringer Ingelheim International GmbH $20.79 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703915297
Principal investigator 1 Boehringer Ingelheim International GmbH $20.79 05/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703925939
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,049.73 04/30/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 704735687
Principal investigator 1 Boehringer Ingelheim International GmbH $41.55 04/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703913761
Principal investigator 1 Boehringer Ingelheim International GmbH $1.79 04/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703913853
Principal investigator 1 Boehringer Ingelheim International GmbH $65.33 04/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703913857
Principal investigator 1 Boehringer Ingelheim International GmbH $1,000.00 03/26/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703908599
Principal investigator 1 Boehringer Ingelheim International GmbH $1,224.00 03/25/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910059
Principal investigator 1 Boehringer Ingelheim International GmbH $1,224.00 03/25/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910061
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 03/25/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910063
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 03/25/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910065
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 03/25/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910067
Principal investigator 1 Boehringer Ingelheim International GmbH $42.18 03/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703907251
Principal investigator 1 Boehringer Ingelheim International GmbH $53.06 03/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703907327
Principal investigator 1 Boehringer Ingelheim International GmbH $42.18 03/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703907329
Principal investigator 1 Boehringer Ingelheim International GmbH $189.60 03/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910053
Principal investigator 1 Boehringer Ingelheim International GmbH $135.43 03/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910055
Principal investigator 1 Boehringer Ingelheim International GmbH $10.55 03/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910057
Principal investigator 1 Boehringer Ingelheim International GmbH $84.36 03/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703926361
Principal investigator 1 Boehringer Ingelheim International GmbH $1,603.00 03/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909967
Principal investigator 1 Boehringer Ingelheim International GmbH $1,567.00 03/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910043
Principal investigator 1 Boehringer Ingelheim International GmbH $1,330.00 03/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910045
Principal investigator 1 Boehringer Ingelheim International GmbH $1,330.00 03/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910047
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 03/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910049
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 03/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703910051
Principal investigator 1 Boehringer Ingelheim International GmbH $900.00 02/25/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703906405
Principal investigator 1 Boehringer Ingelheim International GmbH $735.00 02/25/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703906555
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 02/19/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703905879
Principal investigator 1 Boehringer Ingelheim International GmbH $1,330.00 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703905059
Principal investigator 1 Boehringer Ingelheim International GmbH $1,157.00 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703905199
Principal investigator 1 Boehringer Ingelheim International GmbH $1,157.00 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703905201
Principal investigator 1 Boehringer Ingelheim International GmbH $1,831.00 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703905291
Principal investigator 1 Boehringer Ingelheim International GmbH $1,330.00 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703905443
Principal investigator 1 Boehringer Ingelheim International GmbH $1,330.00 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703905445
Principal investigator 1 Boehringer Ingelheim International GmbH $120.00 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703905511
Principal investigator 1 Boehringer Ingelheim International GmbH $1,330.00 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703905565
Principal investigator 1 Boehringer Ingelheim International GmbH $26.48 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703907247
Principal investigator 1 Boehringer Ingelheim International GmbH $84.90 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703907249
Principal investigator 1 Boehringer Ingelheim International GmbH $42.45 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909951
Principal investigator 1 Boehringer Ingelheim International GmbH $2.29 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909953
Principal investigator 1 Boehringer Ingelheim International GmbH $26.48 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909955
Principal investigator 1 Boehringer Ingelheim International GmbH $40.83 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909957
Principal investigator 1 Boehringer Ingelheim International GmbH $63.67 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909959
Principal investigator 1 Boehringer Ingelheim International GmbH $42.45 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909961
Principal investigator 1 Boehringer Ingelheim International GmbH $100.83 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909963
Principal investigator 1 Boehringer Ingelheim International GmbH $10.42 02/01/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909965
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $35,986.40 01/23/2019 Non-covered Recipient Entity
Saint Louis University
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients with Heart Failure and Impaired Systoli No dispute reported 06/30/2026 639760589
Principal investigator 1 Boehringer Ingelheim International GmbH $190.07 01/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703907235
Principal investigator 1 Boehringer Ingelheim International GmbH $105.59 01/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703907237
Principal investigator 1 Boehringer Ingelheim International GmbH $168.95 01/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703907239
Principal investigator 1 Boehringer Ingelheim International GmbH $116.15 01/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703907241
Principal investigator 1 Boehringer Ingelheim International GmbH $63.36 01/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703907243
Principal investigator 1 Boehringer Ingelheim International GmbH $137.27 01/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 703907245
Principal investigator 1 Boehringer Ingelheim International GmbH $200.63 01/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703909949
Principal investigator 1 Boehringer Ingelheim International GmbH $63.36 01/04/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703926355
Principal investigator 1 Boehringer Ingelheim International GmbH $1,800.00 01/02/2019 Non-covered Recipient Entity
ST LOUIS UNIV
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 703905103